Whether you hope to anticipate and manage new risk in the pursuit of growth, find a seamless global strategy or benchmark your company's pace in responding to change and market pressures, our team can help.

Consult with the best of science and law. The team includes lawyers with higher scientific degrees, many of whom are embedded in industry associations and have experience working as in-house counsel for big pharma, medtech companies and healthcare regulators.



Protecting and Utilizing Your Data in the Life Sciences Ecosystem

data pulse mock-up

Life sciences companies continue to face a myriad of requirements to ensure compliance with a highly regulated industry environment. As businesses innovate in a digital and data-driven world, the interplay between health and data regulations is becoming increasingly complex and challenging.

Explore Data PULSE, a platform that helps you to navigate the complex landscape of data, regulatory and IP protection concerns throughout various stages of the medical product life cycle.

Explore More Resources

Unlocking and Accelerating Growth: Healthcare and Life Sciences in Asia Pacific   Life Sciences Business Evolution Series: How Digital Transformation and Data Are Shaping Business Models
Unlocking and Accelerating Growth   Life Sciences Report 1
Healthcare and life sciences breakthroughs offer opportunities to meet patient needs and create value, but rising costs and market uncertainty also apply significant pressure to operations   Explores how digitally enabled strategies are addressing changing demand and streamlining go-to-market approaches
Life Sciences Business Evolution Series: Funding Growth and the Future of Life Sciences   Life Sciences Business Evolution Series: Shaping Growth - Supply Chains, Manufacturing and Collaboration
Life Sciences Report 2
  Life Sciences Report 3
Looks at how companies are leveraging new and existing sources of growth through transactions   Navigates the emerging trends in manufacturing, supply chain, therapy areas and technology partnerships
Asia Pacific Healthcare and Life Sciences DealSCAPE    Hyper-Hybridity: Defining a New Era of Digital Health Innovation in Asia Pacific
Healthcare Dealscape cover   Hyperhybridity
Explores the defining characteristics of pharmaceutical and biotech transactions in 2022    Looks at the emerging trends and opportunities in digital health ecosystem


Pricing and Healthcare Access in Latin America
Quick Guide
  Chambers Life Sciences Practice Guide 2024
Pricing and Healthcare Access Latin America   Chambers Life Sciences Practice Guide 2024
Answers questions on pharmaceutical pricing, price controls and access to public and private healthcare   Offers commentary on legal and business issues in major healthcare and life sciences markets
Life Sciences Collaborations   Guide to IPOs for Biotech and Pharma Companies
Life Sciences Collaborations   Guide to IPOs Biotech 2023
Issues to consider in executing life sciences collaborations in the COVID-19 era   An overview of the key considerations at each stage of the IPO process
Global Guide to Patent Linkage   Global Medical Cannabis Survey
Global Guide to Patent Linkage   Global Cannabis Dashboard
Legal regimes covering patent linkage doctrines and enforcement options for drug patent rights holders   An interactive global dashboard on the import and export rules in over 100 markets. Please contact Lilli Meldrum to request access.
Telemedicine and Telehealth Legal Framework Overview   Interacting with Healthcare Professionals
Telemedicine survey   Interacting with Healthcare Professionals
Addresses recent developments and future outlook across telemedicine and telehealth, providing guidance on drug distribution and e-pharma   Regulations and traditional practices governing interactions with healthcare professionals (HCPs)
Promoting Medical Products Globally   Brexit: Key Implications for the Healthcare and Life Sciences Sector
Regulations covering ethical business interactions between medical companies and healthcare professionals   Key areas in the healthcare and life sciences sector impacted by the UK's new trading relationship with EU
UAE: Health Data Law    
UAE Health Data Law    
Lists the permitted exceptions and conditions to the data transfer restrictions    


Healthcare & Life Sciences Supply Chain Series

Focuses on the trends, issues and opportunities along each stage of the supply chain life cycle

Laptop showing healthcare and Life Sciences webinar 

FT Big Deal Series: The Healthtech Sector’s Spectacular Surge in SPACs and de-SPACS

A 3-minute video chat on the rise of SPAC investments in the healthtech sector

Biden Supply Chain Policy Video Series: Episode 5 - Pharmaceuticals and Active Pharmaceutical Ingredients

Discusses the impact of the Biden Administration's policies on FDA regulations and government procurement

LSX Masterclass: Partnering & Licensing

Explores how biotech companies can navigate licensing issues and find the right fit for the future

Global Healthcare & Life Sciences Webinar Series

Aims to share legal industry insights and provide practical guidance

The Health Pod

Looks at sector-specific issues and trends

Connect on Tech Podcast Series

Episode 15: Inside the Global Battle for Healthcare Data

Discusses the regulatory restrictions and M&A considerations when protecting healthcare data

Episode 18: Telehealth and COVID-19: US Privacy Changes and Considerations

Updates to US regulations and enforcement priorities that have evolved in response to the pandemic

3R Podcast Series

Episode 10: The Acceleration of Innovation in Healthcare: The Rise of Digital Health Services

Discusses the roles of the government and corporates in fostering innovation in healthcare

TMT Talk

Episode 9: Digital Transformation: Analysis Using the SMART Framework

Insights on technology hot topics such as healthtech

Visit InsightPlus for our latest legal updates covering healthcare and life sciences developments across the globe

Managing the Healthcare & Life Sciences Supply Chain
Learn more about the important considerations at each stage of the supply chain life cycle for healthcare and life sciences companies, including issues which may arise in the areas of M&A, tax, compliance, trade secrets, digital transformation and ESG.

Sustainability Solutions for the Healthcare and Life Sciences Industries
Identifies the key areas driving the shift in sustainability priorities in the sector.

FDA Regulatory Practice
Features our extensive experience in the complex world of products regulated by the FDA, including drugs, medical devices, food, cosmetics, and dietary supplements.

Showcases our multidisciplinary offerings to support clients entering, maintaining and expanding their operations within this fast-growing industry.

Stay informed
Sign up to receive email updates on our other exciting and upcoming healthcare and life sciences events, publications and webinars.
How We Can Help
Benefit from our team's deep industry experience of 60 years, spanning across 45 jurisdictions and key areas of law. Get a unique view of how top FTSE 500 listed companies, mid-market innovators and scale-ups are tackling the challenges of today, and tomorrow.
Find out more about our services